Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.

Erichsen PA, Heerfordt IM, Framke E, Magyari M, Horwitz H

Open source

DOI
10.1016/j.jneuroim.2026.579097
Published
2026 Sep 9
Container
Journal of neuroimmunology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jneuroim.2026.579097,
  title = {Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.},
  author = {Erichsen PA and Heerfordt IM and Framke E and Magyari M and Horwitz H},
  year = {2026},
  journal = {Journal of neuroimmunology},
  doi = {10.1016/j.jneuroim.2026.579097},
  url = {https://doi.org/10.1016/j.jneuroim.2026.579097}
}

RIS

TY  - JOUR
TI  - Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.
AU  - Erichsen PA
AU  - Heerfordt IM
AU  - Framke E
AU  - Magyari M
AU  - Horwitz H
PY  - 2026
JO  - Journal of neuroimmunology
DO  - 10.1016/j.jneuroim.2026.579097
UR  - https://doi.org/10.1016/j.jneuroim.2026.579097
ER  - 

APA

PA, E., IM, H., E, F., M, M., & H, H. (2026). Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.. Journal of neuroimmunology. https://doi.org/10.1016/j.jneuroim.2026.579097

Source records